ArticleCase reports in obstetrics and gynecology2026
A Rare Massive Seromucinous Cystadenoma of the Ovary in a 26-Year-Old Female Persisting for 9 Years: A Case Report.
Article in Case reports in obstetrics and gynecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Rare Massive Seromucinous Cystadenoma of the Ovary in a 26-Year-Old Female Persisting for 9 Years: A Case Report.Case reports in obstetrics and gynecology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Giant ovarian tumors (GOTs) are uncommon ovary neoplasms with no universally accepted definition. They are typically noncancerous, with a mucinous subtype being the most common characteristic. Epithelial ovarian tumors are classified by cell type into serous, endometrioid, clear cell, mucinous, seromucinous, or transitional. Seromucinous cystadenomas are largely asymptomatic and can present with massive dimensions in late diagnoses, especially in low-to-middle-income regions. In this case, a 26-year-old nulliparous Arab woman presented with a giant ovarian cyst in her reproductive age, undiagnosed for 9 years, which turned out to be a benign histopathology of seromucinous cystadenoma. The clinical presentation was nonspecific, as large ovarian cysts are often asymptomatic until they reach a substantial size to affect the quality of life and fertility. She had progressive abdominal swelling first noticed 6 years ago, but she started developing a feeling of fullness, constipation, nausea, vomiting, and urinary hesitancy with painful micturition 5 months prior to presentation with marked distress. The cystadenoma was excised without complications, through the exploratory laparotomy, and a left salpingo-oophorectomy with right cystectomy was performed. Seromucinous cystadenomas were first classified in 2014 by the World Health Organization (WHO) as a new entity and a rare subtype of ovarian epithelial tumors. Patients with benign seromucinous cystadenomas have an excellent prognosis, especially with complete surgical removal. Raising awareness and increasing access to gynecological care in low- and middle-income countries are essential for the long-term well-being and health of patients with giant ovarian cysts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.